Niagen Bioscience, Inc. (FRA:OCD1)

Niagen Bioscience Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 8, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	449	392	97	117	225	243
Market Cap Growth	15.04%	302.70%	-17.00%	-47.82%	-7.52%	6.28%
Enterprise Value	396	364	77	109	199	232
Last Close Price	5.35	5.20	1.32	1.49	3.26	3.88
PE Ratio	25.78	47.50	-	-	-	-
PS Ratio	4.22	4.08	1.29	1.74	3.79	5.02
PB Ratio	7.45	8.81	3.78	4.37	8.06	18.11
P/TBV Ratio	7.48	8.88	3.85	4.48	8.29	19.39
P/FCF Ratio	24.91	33.99	15.45	-	-	-
P/OCF Ratio	24.60	33.54	15.13	-	-	-
EV/Sales Ratio	3.70	3.78	1.01	1.62	3.35	4.79
EV/EBITDA Ratio	21.55	44.12	-	-	-	-
EV/EBIT Ratio	23.89	48.76	-	-	-	-
EV/FCF Ratio	21.99	31.54	12.17	-	-	-
Debt / Equity Ratio	0.04	0.06	0.12	0.15	0.15	0.10
Debt / EBITDA Ratio	0.14	0.27	-	-	-	-
Debt / FCF Ratio	0.14	0.22	0.47	-	-	-
Asset Turnover	1.61	1.62	1.53	1.29	1.40	1.51
Inventory Turnover	3.07	3.21	2.25	2.07	2.05	2.07
Quick Ratio	3.23	2.96	1.57	1.61	1.89	1.17
Current Ratio	4.12	3.57	2.40	2.61	2.78	1.96
Return on Equity (ROE)	38.90%	22.94%	-17.29%	-54.77%	-112.68%	-108.09%
Return on Assets (ROA)	15.60%	7.84%	-6.42%	-20.81%	-35.18%	-31.57%
Return on Capital (ROIC)	21.74%	12.00%	-10.82%	-33.57%	-62.10%	-61.70%
Return on Capital Employed (ROCE)	25.60%	15.40%	-16.30%	-51.50%	-67.30%	-90.70%
Earnings Yield	3.88%	2.10%	-4.59%	-13.19%	-10.61%	-6.70%
FCF Yield	4.02%	2.94%	6.47%	-12.31%	-9.61%	-3.60%
Buyback Yield / Dilution	-10.80%	-4.19%	-7.54%	-3.79%	-10.02%	-7.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.